Work with our network of clinical sites to advance your drugs to the next phase.
PK/PD and Biomarkers
As part of PK studies, we can determine the biomarkers (following oral, intraperitoneal, subcutaneous, topical/epicutaneous delivery) of small molecules as well as their tissue distribution. We accomplish this by using a deuterated standard and an LC-MS/MS approach to identify compounds with oral bioavailability and BBB penetration potential.
We have access to a clinical study population with a focus on CNS disorders.
Talk to Our Experts
We can help every step of the way.